Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Global TIL-based Therapy Market (2nd Edition), 2023-2035
... lymphocytes that comprise of T-cells, B-cells, NK cells and macrophages isolated from the tumor. These lymphocytes selectively mediate the elimination of tumor cells. Ongoing and planned clinical research initiatives in this direction are driven by ... Read More
-
Artificial Intelligence in Oncology Market
... 2022, around 1.9 million individuals are likely to be diagnosed with various types of cancer in the US. During the same year, around 0.6 million cancer-related deaths are anticipated to be reported in the aforementioned ... Read More
-
AI-based Digital Pathology Market, 2022-2035
... multiple disease indications, especially cancer detection. In fact, 70-80% of the total healthcare decisions involved in either diagnosis or treatment of ailments require a pathological assessment. Further, according to the International Agency for Research on ... Read More
-
Cancer Nanotechnology
... With these tools, clinicians can safely and effectively deliver chemotherapy, radiotherapy, and the next generation of immuno- and gene therapies to the tumor. For instance, according to GLOBOCAN, 2020, the global cancer burden increased to ... Read More
-
Non-Small Cell Lung Cancer Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... according to Renub Research. Non-small cell lung cancer is a set of lung cancers that behave and consists of squamous cell carcinoma and adenocarcinoma. Non-small cell lung cancers (NSCLC) remedy alternatives consist of surgical treatment, ... Read More
-
Global Vulvar Cancer Market - 2023-2030
... vulvar cancer market is expected to exhibit a CAGR of 5.9% during the forecast period (2023-2030). The ongoing research and development efforts for novel drugs are driving up demand for vulvar cancer market trends. The ... Read More
-
Global Cancer Biomarkers Market - 2023-2030
... cancer biomarker market is expected to exhibit a CAGR 12.3% during the forecast period (2023-2030). The emergence of liquid biopsy, use of genomic biomarkers, immuno-oncology biomarkers, and integration of artificial intelligence (AI) are driving up ... Read More
-
Global Pancreatic Cancer Market - 2023-2030
... Pancreatic Cancer market is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030). The pancreas can develop both malignant and non-cancerous tumors, among other growths. Pancreatic ductal adenocarcinoma, the most prevalent form ... Read More
-
Cancer Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global cancer biomarkers market is poised for significant growth and expansion in the upcoming years. Cancer biomarkers play a crucial role in early detection, diagnosis, and cancer monitoring applications by indicating the presence of cancer ... Read More
-
Minimal Residual Disease Testing: Global Markets and Technologies
... the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection. The report analyzes leading and emerging technologies, applications, end-user, and product pipeline details for minimal residual disease testing. Profiles ... Read More
-
Global Cell Freezing Media Market Size study & Forecast, by Product (DMSO, Glycerol) by Application (Stem Cell lines, Cancer Cell Lines, Others), by End Use (Pharmaceutical and Biotechnological Companies, Research & Academic Institutes, Others), and Regional Analysis, 2023-2030
... Regional Analysis, 2023-2030 Global Cell Freezing Media Market is valued approximately at USD 140.1 million in 2022 and is anticipated to grow with a healthy growth rate of more than 9.62% over the forecast period ... Read More
-
Pain Management Drugs Market Size - By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine), Indication (Arthritic, Neuropathic, Cancer), Pain Type (Chronic, Acute), Distribution Channel (Hospital, Retail, Online), Global Forecast (2023 - 2032)
... Market size is poised to record 4.5% CAGR from 2023-2032. The scaling R&D investments by pharmaceutical companies for creating novel pain management drugs and formulations for enhanced efficacy and reduced side effects will drive the ... Read More
-
Chordoma Disease Therapeutics Market
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Chordoma tumors can press the spine, brain, and nerves as they grow causing ... Read More
-
Global Neoantigen Cancer Vaccine Market Report and Forecast 2023-2031
... for effective and personalized treatment across the globe. The market size is anticipated to grow at a CAGR of 69.4% during the forecast period of 2023-2031 to achieve a value of USD 8872.5 million by ... Read More
-
Global Hodgkin’s Lymphoma Market - 2023-2030
... Hodgkin’s lymphoma market is expected to exhibit a CAGR of 9.8% during the forecast period (2023-2030). The increasing technological advancements and the growing investments in novel products are driving up demand for Hodgkin’s lymphoma market ... Read More
-
Global Non-Hodgkin Lymphoma Market - 2023-2030
... non-Hodgkin lymphoma market is expected to exhibit a CAGR of 8.2% during the forecast period (2023-2030). The NHL market has witnessed a notable emphasis on the development and commercialization of targeted therapies. Biomarker identification and ... Read More
-
Global Breast Cancer Drugs Market Market - 2023-2030
... 2030. The Global Breast Cancer Drugs Market is expected to exhibit a CAGR of 9.2% during the forecast period 2023-2030. The increasing demand for discovering novel therapies and optimizing existing treatments are driving up demand ... Read More
-
Global Bone Cancer Market - 2023-2030
... Bone Cancer Market is expected to exhibit a CAGR of 4.8% during the forecast period 2023-2030. Bone cancer can begin in any bone in the body, but it most commonly affects the pelvis or the ... Read More
-
Myelofibrosis Treatment Market by Type (Targeted therapy, Chemotherapy and Others), Distribution Channel (Hospital pharmacies, Retail and specialty pharmacies and Online pharmacies) and Geography (North America, Europe, APAC and RoW)-Forecast up to 2027
... unusual type of blood cancer. The bone marrow becomes scarred, which makes it complicated to make blood cells. It belongs to a group of diseases referred as myeloproliferative disorders or myeloproliferative neoplasms. Stem cells are ... Read More
-
Occupational Medicines Market by Application (Chemical Poisoning, Psychological Disorder, Noise-Induced Hearing Loss & Vibration, Skin Disorder, Chronic Respiratory Disease, Pneumoconiosis, Musculoskeletal Disorder, Cancer, and Others), and Industry (Agriculture & Forestry, Construction, Manufacturing, Petroleum & Mining, Transportation, and Others) - Global Opportunity Analysis and Industry Forecast up to 2027
... Transportation, and Others) - Global Opportunity Analysis and Industry Forecast up to 2027 The occupational medicines market refers to the segment of the healthcare industry that focuses on providing medical services and solutions for workplace-related ... Read More
-
Natural Killer Cells Therapeutics Market by Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2027
... Analysis and Industry Forecast, 2027 The Natural Killer (NK) Cells Therapeutics market refers to the pharmaceutical products and therapies aimed at utilizing and enhancing the functions of natural killer cells for therapeutic purposes. Natural killer ... Read More
-
Non-Small Cell Lung Cancer Market by Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Others and Adenocarcinoma), Treatment Type (Chemotherapy, Targeted Therapy and Immunotherapy), Distribution Channel (Hospital Pharmacy, Drug Store and Retail Pharmacy and Online Pharmacy) and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027
... and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027 Non-small cell lung cancer is a form of lung cancer, where malignant tumor cells are formed in the lungs. It comprises of ... Read More
-
Lung Cancer Screening Market Size and Forecast to 2030 - Global Analysis by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)
... Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others) The lung cancer screening market size is expected to grow from US$ 2,326.5 million in 2022 to US$ ... Read More
-
Lung Marker Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 731.0 Million by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028. Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or ... Read More
-
Lung Cancer Screening Market Size and Forecast to 2030 - COVID-19 Impact and Global Analysis by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)
... Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others) The lung cancer screening market size is expected to grow from US$ 2,326.5 million in ... Read More
Research Assistance
